New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis

Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous system (CNS), with an inflammatory demyelinating basis and a progressive course. The course of the disease is very diverse and unpredictable. Patients face many problems on a daily basis, such as problems with visio...

Full description

Bibliographic Details
Main Authors: Ewa Zielińska-Nowak, Lidia Włodarczyk, Joanna Kostka, Elżbieta Miller
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/11/3592
_version_ 1797548573269688320
author Ewa Zielińska-Nowak
Lidia Włodarczyk
Joanna Kostka
Elżbieta Miller
author_facet Ewa Zielińska-Nowak
Lidia Włodarczyk
Joanna Kostka
Elżbieta Miller
author_sort Ewa Zielińska-Nowak
collection DOAJ
description Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous system (CNS), with an inflammatory demyelinating basis and a progressive course. The course of the disease is very diverse and unpredictable. Patients face many problems on a daily basis, such as problems with vision; sensory, balance, and gait disturbances; pain; muscle weakness; spasticity; tremor; urinary and fecal disorders; depression; and rapidly growing fatigue, which significantly influences quality of life among MS patients. Excessive fatigue occurs in most MS patients in all stages of this disease and is named MS-related fatigue. The crucial issue is the lack of effective treatment; therefore, this review focuses not only on the most common treatment methods, but also on additional novel therapies such as whole-body cryotherapy (WBC), functional electrical stimulation (FES), and non-invasive brain stimulation (NIBS). We also highlight the advantages and disadvantages of the most popular clinical scales used to measure fatigue. The entire understanding of the origins of MS-related fatigue may lead to the development of more effective strategies that can improve quality of life among MS patients. A literature search was performed using MEDLINE, EMBASE, and PEDro databases.
first_indexed 2024-03-10T15:02:29Z
format Article
id doaj.art-cb5711be8a134c8f86e80d83ec75f1ef
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T15:02:29Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-cb5711be8a134c8f86e80d83ec75f1ef2023-11-20T20:07:27ZengMDPI AGJournal of Clinical Medicine2077-03832020-11-01911359210.3390/jcm9113592New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple SclerosisEwa Zielińska-Nowak0Lidia Włodarczyk1Joanna Kostka2Elżbieta Miller3Department of Neurological Rehabilitation, Medical University of Lodz, Milionowa 14, 90-001 Lodz, PolandDepartment of Occupational Diseases and Environmental Health, Nofer Institute of Occupational Medicine, 91-348 Lodz, PolandDepartment of Gerontology, Medical University of Lodz, Milionowa 14, 90-001 Lodz, PolandDepartment of Neurological Rehabilitation, Medical University of Lodz, Milionowa 14, 90-001 Lodz, PolandMultiple sclerosis (MS) is the most common autoimmune disease of the central nervous system (CNS), with an inflammatory demyelinating basis and a progressive course. The course of the disease is very diverse and unpredictable. Patients face many problems on a daily basis, such as problems with vision; sensory, balance, and gait disturbances; pain; muscle weakness; spasticity; tremor; urinary and fecal disorders; depression; and rapidly growing fatigue, which significantly influences quality of life among MS patients. Excessive fatigue occurs in most MS patients in all stages of this disease and is named MS-related fatigue. The crucial issue is the lack of effective treatment; therefore, this review focuses not only on the most common treatment methods, but also on additional novel therapies such as whole-body cryotherapy (WBC), functional electrical stimulation (FES), and non-invasive brain stimulation (NIBS). We also highlight the advantages and disadvantages of the most popular clinical scales used to measure fatigue. The entire understanding of the origins of MS-related fatigue may lead to the development of more effective strategies that can improve quality of life among MS patients. A literature search was performed using MEDLINE, EMBASE, and PEDro databases.https://www.mdpi.com/2077-0383/9/11/3592multiple sclerosisfatiguepharmacological treatmentrehabilitationphysical activityaerobic training
spellingShingle Ewa Zielińska-Nowak
Lidia Włodarczyk
Joanna Kostka
Elżbieta Miller
New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
Journal of Clinical Medicine
multiple sclerosis
fatigue
pharmacological treatment
rehabilitation
physical activity
aerobic training
title New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
title_full New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
title_fullStr New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
title_full_unstemmed New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
title_short New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
title_sort new strategies for rehabilitation and pharmacological treatment of fatigue syndrome in multiple sclerosis
topic multiple sclerosis
fatigue
pharmacological treatment
rehabilitation
physical activity
aerobic training
url https://www.mdpi.com/2077-0383/9/11/3592
work_keys_str_mv AT ewazielinskanowak newstrategiesforrehabilitationandpharmacologicaltreatmentoffatiguesyndromeinmultiplesclerosis
AT lidiawłodarczyk newstrategiesforrehabilitationandpharmacologicaltreatmentoffatiguesyndromeinmultiplesclerosis
AT joannakostka newstrategiesforrehabilitationandpharmacologicaltreatmentoffatiguesyndromeinmultiplesclerosis
AT elzbietamiller newstrategiesforrehabilitationandpharmacologicaltreatmentoffatiguesyndromeinmultiplesclerosis